21sme.com

Reuters - Health-care products maker Johnson & Johnson won U.S. approval to sell a new HIV drug called Intelence for patients with resistance to other therapies, U.S. officials said on Friday.

U.S. pleads for patience in crisis repair efforts (Reuters)

GM, Chrysler in merger talks: source (Reuters)

Ford plans to sell Mazda shares: source (Reuters)

Paulson says U.S. planning to buy financial equity (Reuters)

G7 pledges urgent, decisive action as markets reel (Reuters)

Market ends mostly lower after wild session (Reuters)

G7 discussing bank support measures: source (Reuters)

Bush calls for calm amid global stock market panic (Reuters)

Morgan Stanley, Goldman shares tumble (Reuters)

Judge says Wachovia hearing possible Monday (Reuters)

Risk aversion, bank woes fuel tumultuous slide (Reuters)

World stocks slump on Dow open (AP)

Money-market funds flock to guarantee program (AP)

Record Label Gives Fans A Reason To Buy

Books Are The Souvenir Edition For Your Idea

Apple Dumps Another Game For Being 'Too Similar' To Tetris

Dear Bands: No Matter How Much You Dislike John McCain, He Can Most Likely Use Your Song

NSA Abused Wiretap Rights: Intercepted, Shared Private Calls Of Americans

Patent Lawsuit Silly Season: TechCrunch Sued For Patent Infringement After Critical Blog Post

Apparel chains report dismal September sales (AP)